Markets:

Overview

News

Currencies

International

Treasuries

Eaton Vance Ohio Municipal Income Trust (NQ:EVO)

3.140 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Nov 12, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Eaton Vance Ohio Municipal Income Trust

< Previous 1 2 3 4 5 6 7 8 9 Next >

uniQure, Hertz Global, Eli Lilly And Other Big Stocks Moving Higher On Thursday ↗

April 17, 2025

Via Benzinga

Earnings Scheduled For April 17, 2025 ↗

April 17, 2025

Via Benzinga

Evotec SE Unveils New Strategy and Provides 2025 Guidance Bolstered by Strong Q4 2024 Results

April 17, 2025

Via ACCESS Newswire

Evotec Announces Key Progress in Neuroscience Collaboration with Bristol Myers Squibb

March 04, 2025

Via ACCESS Newswire

Evotec Announces Change in Management Board

February 26, 2025

Via ACCESS Newswire

Evotec Announces Change in Management Board

November 29, 2024

Via ACCESSWIRE

Comment on Withdrawn Non-Binding Offer

November 22, 2024

Via ACCESSWIRE

Evotec SE to Announce Results for Financial Year 2024 on 17 April 2025

April 10, 2025

Via ACCESS Newswire

Evotec Receives Grant from Korean Government to Develop Novel Antibody-based Treatments for Lung Diseases

January 22, 2025

Via ACCESS Newswire

Ingles Markets, Tesla And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

December 27, 2024

Via Benzinga

Evotec SE announces first projects for LAB eN(2) drug discovery accelerator with Novo Nordisk

December 11, 2024

Via ACCESSWIRE

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 22, 2024

Via Benzinga

Insights into Evotec's Upcoming Earnings ↗

November 05, 2024

Via Benzinga

Evotec Announces Sale of API Manufacturing Facility to Monacum Partners

November 04, 2024

Via ACCESSWIRE

Evotec and Bristol Myers Squibb Expand Proteomics Partnership

October 22, 2024

Via ACCESSWIRE

Halozyme Withdraws Evotec Bid After Rebuff, Reaffirms Strong Growth Outlook ↗

November 22, 2024

Halozyme stock rises after withdrawing its €2B acquisition offer for Evotec, while reaffirming strong growth outlook for 2024.

Via Benzinga

Intuit Issues Weak Forecast, Joins Reddit And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

November 22, 2024

Via Benzinga

Large Pharma Partner Halozyme Therapeutics Offers To Acquire Germany-Based Evotec For ~$2 Billion ↗

November 15, 2024

Halozyme offers to acquire Evotec for €11.00 per share, boosting Evotec's value to €2 billion. The merger aims to enhance Halozyme's revenue growth and portfolio.

Via Benzinga

Comment on Media Report

November 14, 2024

Via ACCESSWIRE

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 11, 2024

Via Benzinga

Private Equity Triton Partners Takes Around 10% Stake In Evotec, Reportedly Mulls Potential Takeover Deal ↗

November 11, 2024

Evotec sees a 13.3% stock rise amid reports of Triton Partners eyeing a potential buyout after acquiring a 9.99% stake in the company.

Via Benzinga

Exact Sciences Posts Downbeat Results, Joins Super Micro Computer, Honda Motor And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

November 06, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 06, 2024

Via Benzinga

Evotec SE Reports 9M 2024 Results: Strategic Progress and Successful Expansion Amid Challenging Market Conditions

November 05, 2024

Via ACCESSWIRE

Integra LifeSciences Posts Upbeat Results, Joins Air Transport Services, Freshpet, Yum China And Other Big Stocks Moving Higher On Monday ↗

November 04, 2024

Via Benzinga

Evotec SE to Announce Results for the First Nine Months 2024 on 06 November 2024

October 29, 2024

Via ACCESSWIRE

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 23, 2024

Via Benzinga

Why Is Evotec Stock Gaining Today? ↗

October 23, 2024

Evotec stock is up following progress in its partnership with Bristol Myers Squibb, including a $50 million payment.

Via Benzinga

Sherwin-Williams, Apple And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

October 07, 2024

Via Benzinga

Novo Nordisk And Evotec Collaborate On Stem Cell-Based Therapy Development ↗

September 26, 2024

Evotec and Novo Nordisk have partnered to develop off-the-shelf cell therapy products. The collaboration will focus on advancing stem cell-based therapies for potential commercialization.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.